IMAGE: This is Dr. Fiona McKay from the Westmead Institute for Medical Research. view more Credit: Westmead Institute for Medical Research New research into Amyotrophic Lateral Sclerosis (ALS) – also known as motor neuron disease – shows that specific immune cells may help slow progression of the disease, an important step towards developing new therapies to...
Post
New research suggests staying active, within reason, is the best medicine for back pain
Credit: University of Alberta New University of Alberta research is putting some kinks in assumptions about treating low back pain. While it may seem logical to take a pain reliever and rest up in bed, it’s not the best way to treat occasional low back pain, said Doug Gross, a professor in the Faculty of...
Post
Nutrient-deficient diet a key Type 2 diabetes contributor for South Asians living in U.S.
The new UT Southwestern study showed that U.S. South Asians with Type 2 diabetes consumed fewer calories but also consumed less beneficial nutrients than healthy South Asians. DALLAS – March 21, 2018 – Less nutritious dietary choices made by South Asians living in developed countries like the U.S. are a key contributor to the group’s rising...
Post
Can beets tackle Alzheimer’s at its root?
Alzheimer’s disease is characterized by beta-amyloid plaques in the brain that disrupt the normal functioning of neurons. Could a common vegetal pigment provide the fix? A pigment found in beets may lead the way to better Alzheimer’s drugs, new research suggests. The most prominent physiological characteristic of Alzheimer’s disease is the over-accumulation of clusters of...
Post
How a novel protein may combat cancer
Breaking research published in the journal Nature describes a new anti-cancer protein. The finding could help to spot cancer earlier and treat it more effectively. Using cuting edge techniques, Swiss researchers find a new cancer-fighting protein. Each year, around 31,000 people in the United States develop liver cancer, also known as hepatocellular carcinoma . And, roughly...
Post
Boosting enzyme may help improve blood flow, fitness in elderly
An enzyme called SIRT1 declines in the blood vessels with age and restoring it reverses the effects of vascular aging. After receiving a supplement called NMN, older mice showed increased capillary density, blood flow, mobility, and …more As people age, their blood-vessel density and blood flow decrease, which is why it’s harder to maintain muscle...
Post
aerSleep System for Obstructive Sleep Apnea (Interview)
TTP Ventus, UK-based developer of Disc Pump, a tiny, quiet, and very efficient pump, and Sommetrics, US-based creator of aerSleep negative-pressure treatment system for obstructive sleep apnea, teamed up to develop the slimmed-down tetherless aerSleep system. aerSleep has just recently been approved for marketing to patients in Canada. Obstructive sleep apnea is caused by airway collapse during sleep,...
Post
Newly Developed Microneedles Can Dissolve in the Skin to Deliver Drugs
No one likes getting a shot, so it may come as good news that a team of researchers from the University of Texas at Dallas have created painless, biodegradable microneedles that can break off in the skin and dissolve to administer drugs. A fear of needles may soon be a thing of the past, as...
Post
Nanostructures created by UCLA scientists could make gene therapies safer, faster and more affordable
UCLA scientists have developed a new method that utilizes microscopic splinter-like structures called “nanospears” for the targeted delivery of biomolecules such as genes straight to patient cells. These magnetically guided nanostructures could enable gene therapies that are safer, faster and more cost-effective. The research was published in the journal ACS Nano by senior author Paul...
Post
Grass peptide immunotherapy cuts seasonal allergy symptoms
Ralph Mösges, M.D., from the Institute of Medical Statistics, Informatics and Epidemiology in Cologne, Germany, and colleagues assessed the clinical efficacy and safety of a cumulative dose of 170 μg LPP administered subcutaneously over three weeks among 554 adults with grass pollen rhinoconjunctivitis. The participants were randomized in a 1:2 ratio to receive subcutaneous injections...